Drug Type Synthetic peptide |
Synonyms anti-inflammatory tetrapeptide (Logical), TNF receptor-1 antagonist (Logical), LT-ZMP001 |
Target |
Action inhibitors |
Mechanism TNFR1 inhibitors(Tumor necrosis factor receptor superfamily member 1A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Discovery | United States | - |